Entering text into the input field will update the search result below

Alere's point-of-care RSV test gets CLIA waiver allowing its use in non-lab settings

Mar. 07, 2017 8:01 AM ETAlere Inc. (ALR-OLD) StockBy: Douglas W. House, SA News Editor
  • The FDA grants a CLIA waiver to Alere's (NYSE:ALR-OLD) i RSV test, cleared for marketing in the U.S. in August 2016. The waiver allows the test to be used in non-clinical laboratory settings such as a physician's office, a walk-in clinic or a hospital emergency room.
  • It is the company's third test so designated.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ALR-OLD--
Alere Inc.